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Abstract
Although urinary 1,6-hexamethylene diamine (HDA) is a useful biomarker of exposure to 1,6-
hexamethylene diisocyanate (HDI), a large degree of unexplained intra- and inter-individual
variability exists between estimated HDI exposure and urine HDA levels. We investigated the
effect of individual and workplace factors on urine HDA levels using quantitative dermal and
inhalation exposure data derived from a survey of automotive spray painters exposed to HDI.
Painters' dermal and breathing-zone HDI-exposures were monitored over an entire workday for up
to three separate workdays, spaced approximately one month apart. One urine sample was
collected before the start of work with HDI-containing paints, and multiple samples were collected
throughout the workday. Using mixed effects multiple linear regression modeling, coverall use
resulted in significantly lower HDA levels (p = 0.12), and weekday contributed to significant
variability in HDA levels (p = 0.056). We also investigated differences in urine HDA levels
stratified by dichotomous and classification covariates using analysis of variance. Use of coveralls
(p = 0.05), respirator type worn (p = 0.06), smoker status (p = 0.12), paint-booth type (p = 0.02),
and more than one painter at the shop (p = 0.10) were all found to significantly affect urine HDA
levels adjusted for creatinine concentration. Coverall use remained significant (p = 0.10), even
after adjusting for respirator type. These results indicate that the variation in urine HDA level is
mainly due to workplace factors and that appropriate dermal and inhalation protection is required
to prevent HDI exposure.
Introduction
Due to their work with HDI-containing products, auto-body painters risk becoming
sensitized to HDI and developing occupational asthma.1,2 The effectiveness of the exposure
protection methods used, therefore, are important to understand. The use of urinary 1,6-
hexamethylene diamine (HDA) as a biomarker for inhalation exposure to 1,6-hexamthylene
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diisocyanate (HDI) has been established.3–7 Previously, we demonstrated a quantitative
linear relationship between dermal exposure to HDI and urine HDA levels.3 We further
concluded that creatinine should be used as an independent variable in exposure modeling to
account for the water content in the urine sample collected from a worker exposed to
HDI.3,8 However, in our exposure models relating inhalation and dermal HDI exposure to
urine HDA levels, considerable intra- and inter-person variability was observed,3 which
would compromise the use of urine HDA as a biomarker for occupational exposure to HDI.
To effectively use individual urine HDA levels in monitoring exposure, evaluating personal
protection, and establishing regulatory compliance, determining the cause(s) of the
variability is critical.
HDA levels in hydrolyzed urine may be derived from both the non-enzymatic hydrolysis of
HDI as well as monoacetyl-HDA and diacetyl-HDA formed from N-acetyl transferase 1
(NAT1) activity. Upon acid hydrolysis of the urine sample during analysis, protein adducts
formed due to direct reaction with HDI or as a product of HDI metabolism may be broken
down and released in the form of HDA.9–12 Thus, a person's inherent ability to metabolize
HDI (e.g., metabolic rate, genetic polymorphisms) may be only one contributing factor to
the elimination rate of HDA after exposure to HDI. Liu et al.7 observed considerable
variability between exposure to HDI biuret, a HDI oligomer, with a small amount of the
HDI monomer, and urine HDA levels that was attributable to subjects over 32 years old
having significantly higher pre-exposure HDA levels but not post-exposure levels than
younger subjects. In addition, they observed higher HDA levels both at pre-exposure and
immediately post-exposure in non-smokers compared to smokers, but the difference was
statistically significant for pre-exposure levels only. Job category, age, and years working in
the automotive spray-painting industry did not affect the individual variability in urine HDA
levels in their study.
Uncertainty in the relationship between HDI exposure and urine HDA levels is mostly due
to the lack of knowledge of the complete physical and biological processes from exposure to
elimination. Several researchers have noted that the amount of HDA excreted is only a small
amount of the actual exposure dosage.5,6,13,14 Brorson et al.5 observed that subjects
classified as slow-acetylators excreted more of the inhaled HDI dose than subjects classified
as rapid-acetylators, while Brorson et al.13 observed the opposite with orally administered
HDA. However, this difference may be due to route and type of exposure. In order to
investigate the cause(s) for the intra- and inter-person variability observed in urine HDA
levels after occupational exposure to HDI,3 we examined the individual and work




The study population has been described previously.3,15 Briefly, spray painters in
automotive repair shops who worked with HDI-containing paint were recruited for the study
in the Raleigh-Durham area of North Carolina and the Puget Sound area of Washington
State. Eleven shops in North Carolina with a total of 15 workers and 25 shops in
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Washington with a total of 32 workers participated in the study. Each exposed worker was
monitored over the workday on up to three separate days over a 12-month period. Due to
attrition, five subjects were monitored once and 15 subjects were monitored twice. The
subjects were all male, ranging in age from 21 to 59 years with an average age of 34 years.
Thirty subjects identified themselves as white, nine as Hispanic, four as African-American,
one as Asian, one as Native American, and two as mixed ethnicity. This study was approved
by the Institutional Review Board in the Office of Human Research Ethics at the University
of North Carolina at Chapel Hill and by the Washington State Institutional Review Board at
the Washington State Department of Social and Health Services.
A questionnaire was developed for this study and information on worker age, weight, height,
ethnicity, and medical history with regard to susceptibility to occupational asthma (i.e., had
allergies, asthma, or medical problems after painting) was collected. No one reported
diisocyanate-induced asthma. Information on the type of personal protective equipment
(PPE) that they typically wore during painting and the maintenance schedule of their PPE
and paint booth was also obtained.
Dermal and breathing-zone air sampling
Personal breathing-zone and dermal tape-strip sampling were performed to estimate
inhalation and dermal exposure during every spray-application of HDI-containing paints and
coatings.16 The collection and analyses of the breathing-zone and dermal tape-strip samples
have been published previously.15,17 On each sampling visit, breathing-zone air samples
were collected during each HDI-containing painting task, and tape-strip samples were
collected immediately following each task. The painter was observed during the paint tasks
to note the duration of exposure and the type of respirator worn. The Assigned Protection
Factor (APF) designated by the Occupational Safety and Health Administration18 for the
respirator worn by a worker (none, APF = 1; air purifying half-face, APF = 10; air-purifying
full-face, APF = 50; supplied air full-face or hood, APF = 1000; powered air-purifying
(PAPR), full-face or hood, APF = 1000) was used to adjust the measured breathing-zone
concentrations (BZC) in order to account for the respiratory protection in inhalation
exposure levels used in the analyses.
Urine sampling
The urine sampling protocol has been published previously.3 Briefly, during each sampling
visit, urine samples were obtained from the worker each time he urinated. At a minimum,
one end-of-day sample was collected. An average of 2.5 post-exposure urine samples were
obtained per worker per day. The maximum number of samples obtained from a worker on a
single day was eight. A total of 282 post-exposure urine samples were collected.
HDA analysis
The analysis of HDA levels in the urine samples collected from the spray painters has been
published previously.3 Briefly, an internal standard 1,7-diaminoheptane (HpDA) was added
to the urine sample before hydrolysis at 100 °C with concentrated sulfuric acid. The samples
were cooled, neutralized with saturated sodium hydroxide (NaOH), mixed with sodium
chloride, and then extracted three times with toluene. The samples were then derivatized
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with heptafluorobutyric anhydride at 55 °C, cooled, and potassium phosphate buffer added
to remove excess derivatizing agent. The organic layer was retained, and sodium sulfate was
added to dry the sample. The organic solution was moved to a clean vial and dried. The
samples were then reconstituted with 200 μl ethyl acetate, sonicated, and transferred to GC
vial inserts. The samples were again dried to completion and reconstituted with 60 μl ethyl
acetate. The samples were analyzed by gas chromatography-mass spectrometry (GC-MS)
(Thermo, Austin, TX) in negative chemical ionization mode with methane as the reagent
gas. The HDA and HpDA were determined using selective ion monitoring at m/z 448 and
m/z 462, respectively.
Standard curves were prepared by spiking pooled urine from four unexposed individuals
with HDA. Each standard curve consisted of a reagent blank (no HDA or HpDA), a negative
control (HpDA but no HDA), and nine different HDA concentrations (0.08 to 20 μg/l) with
HpDA (1.5 μg/l). Weighted linear regression was used to construct a standard curve using
the HDA/HpDA ratio.19 Different weighting factors (w = x−0.5, x−1, x−2, y−0.5, y−1, y−2,
y−1.5; where x = HDA/HpDA instrument response ratio, y = HDA concentration) were
evaluated for fitting standard curves. The weighting factor that gave the smallest sum of
absolute relative error as a percentage of the nominal concentration was used for fitting the
standard curve.19 The standard curve was linear from 0 to 20 μg/l (w = y−2, R2 = 0.98). The
method detection limit (MDL) of 0.04 μg/l was calculated using the MDL procedure
established by U.S. EPA.20
Creatinine analysis
The creatinine concentration in the urine was determined using the Creatinine Companion
assay kit (Exocell, Inc., Philadelphia, PA)21,22 as described previously.3 Briefly, samples
were diluted in distilled water and then aliquoted, in duplicate, into a microtiter plate along
with creatinine standards, in duplicate. NaOH was added to alkaline picrate reagent, and this
solution was added to each well. The plate was incubated at room temperature for 10 min,
and the absorbance determined at 500 nm (Emax, Molecular Devices, Sunnyvale, CA). The
acid reagent provided with the kit was then added to each well, and the absorbance at 500
nm determined after a 5-min incubation at room temperature. The difference between the
two absorbance values was recorded for each well. A standard curve was calculated based
on the standards and their responses. Unknown samples were evaluated by comparing their
responses to the standard curve.
Statistical analysis
The data were analyzed using SAS statistical software (SAS 9.1; SAS Institute Cary, NC).
BZC and dermal levels of HDI and urine HDA levels were natural log-transformed to satisfy
normality assumptions (Shapiro Wilks W > 0.85) prior to statistical analysis. Creatinine
concentrations were approximately normally distributed (W = 0.89). However, natural log-
transformation of the creatinine concentrations improved the normality (W = 0.96).
Due to the relatively high percentage of non-detectable levels of HDA in the urine samples
(38%) as well as HDI in the breathing-zone air (9%) and dermal tape-strip (63%) samples,
multiple imputation was used to impute data below the detection limits. For each
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observation with a non-detectable level, ten values were imputed. Methods for performing
the multiple imputation of the exposure data have been described previously.3,15,17 Briefly,
we applied logarithmic transformation to all exposure variables to make them normally
distributed before imputation and imputed from truncated multivariate normal distributions
with an upper truncation at the logarithmic transformed limit of detection for HDI or MDL
for HDA. PROC MIANALYZE was used to combine the results of the analyses carried out
on the 10 imputed datasets and to obtain valid estimates and statistical inferences. Averages
were computed where PROC MIANALYZE could not be used (i.e. fit statistics, t-tests, and
analysis of variance).
We investigated the effect of different covariates on the relationship between HDI exposure
(inhalation and dermal) and post-exposure urinary HDA levels by including the covariates
as independent variables in the mixed effects multiple linear regression models (PROC
MIXED). Each urine sample was used as an individual observation. Previously, we reported
that the measured personal BZC adjusted by the APF, as designated by the Occupational
Safety and Health Administration,18 for the respirator worn by the worker provided a better
model fit when investigating the effect of dermal and inhalation exposure on urine HDA
levels.3 Since the adjusted BZCs provided the best-fit model, we used BZCs adjusted for
APF in the models presented here.
The mixed effects multiple linear regression model to investigate the relative influences of
different covariates including creatinine concentration to the relationship between urine
HDA level (unadjusted for creatinine concentration) and dermal and inhalation exposure is
as follows:
(1)
where Yij represents the natural logarithm of the urinary HDA concentration (the jth
measurement obtained for the ith worker), X1ij represents the natural logarithm of the
measured BZC adjusted for the APF (BZC-APF) based on the respirator worn, X2ij
represents the natural logarithm of the measured dermal exposure, X3ij represents the natural
logarithm of the creatinine concentration of the urine sample, X4ij represents the covariate
being tested, and αi and εij represent the random effects associated with worker (αi for i =
1,2,…,48 workers) and an error term (εij for j = 1,2,…,16 measurements per worker).
Models were constructed using standard regression techniques, and model fit was examined
with regression diagnostics such as residual analysis. The statistical significance was
evaluated at α-level 0.10.
Using this model, we assumed that αi and εij are mutually independent and normally
distributed with means of zero and respective variances  and  representing the between
and within-worker variance components, where total variance . It is also
assumed that Yij is normally distributed with mean μY = β0 + β1X1ij + β2X2ij and variance .
Compound symmetry was used for the covariance structure.
Cumulative exposure measures for BZC-APF and dermal exposure were used in the
statistical analyses. Cumulative exposure was calculated by summing all the respective
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exposure levels that occurred before a urine sample was obtained, as provided by the
following equation,
(2)
where Ct is the concentration at time t of the measured dermal or BZC-APF exposure, T is
the time of the urine sample, and t is the exposure time.
A list of all covariates tested including the descriptions and the ranges for the variables is
provided in Table 1. These covariates included dichotomous variables such as the type of
PPE worn by the painter (gloves, long sleeves, coveralls, and hat), multiple painters at shop,
smoker vs. non-smoker, allergies, or asthma. Categorical variables such as ethnicity, the
weekday of sampling, and the type of paint booth used (cross-draft, semi-downdraft, or
downdraft) were also tested. We also included continuous variables such as worker's age,
BMI, and number of clear coats tasks performed in the past week. Candidate covariates for
the mixed effects multiple linear regression models were selected by running separate
models that considered only the exposure variables, creatinine, the candidate covariate, and
the interaction terms between the candidate covariate and dermal or inhalation exposure (i.e.
the covariates were tested one at a time). From these models, those variables with p-values
<0.15 were used to build the final models. Final models were built using a backward
elimination procedure in which the least significant variables (p < 0.15) were eliminated one
at a time. Statistically nonsignificant main effects were always retained if their respective
interaction terms were significant.
Although we reported that BZC-APF provided the best fit in the mixed effect models,3 we
also chose to investigate multiple linear regression models where X1ij represented BZC
unadjusted for APF and X4ij represented the multi-class respirator type where X4ij = 0 for
half-face cartridge respirator, X4ij = 1 for full-face cartridge respirator, and X4ij = 2 for air-
supply respirator or PAPR. The respirator types were categorized into these four levels
because they were categorized in this manner for designating APFs.
In addition, we used a marginal R2 statistic proposed by Vonesh and Chinchilli23 to assess
the goodness-of-fit of fixed effects in our mixed effects multiple linear regression models.
Several R2 statistics have been proposed for assessing the goodness-of-fit of fixed effects for
models.24,25 However, marginal R2 statistic is more appropriate than conditional R2 statistic
for estimating explained variability from fixed effects as marginal R2 statistic does not use
random effects in the computation of predicted means that lead to residuals.24 Orelien and
Edwards24 found this statistic to perform extremely well at differentiating between full and
reduced models and not diverging when models were over-fitted.
We also investigated the effect of different covariates on the urine HDA levels using
analysis of variance (ANOVA). For this analysis, we used hypothetical, pooled urine
samples consisting of all post-exposure urine samples on a given workday. Each worker has
n number of post-exposure urine samples, and each urine sample has a volume Vj, HDA
level Yj (μg/l), and creatinine concentration Cj (g/l). If all post-exposure urine samples were
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pooled, the pooled urine would have volume VT, HDA level YT (μg/l), and creatinine




CT is calculated similarly to eqn (4). If creatinine is excreted at a constant rate, then
(5)
Then with substitution and rearrangement,
(6)
We calculated the geometric mean (GM) and geometric standard deviation (GSD) of the
hypothetical pooled HDA levels from the natural log-transformed data (PROC MEANS)
stratified by class-type covariates. Statistical analysis of the stratified data was performed
using PROC TTEST for dichotomous variables and PROC GLM for covariates with more
than two levels (at α-level 0.10) across each imputed data set and p-values averaged. All
dichotomous and categorical variables listed in Table 1 were tested in this manner.
However, the covariates describing the painter's allergies or asthma symptoms were not
tested with ANOVA, due to the limited number of workers who reported having allergies (n
= 11) or asthma (n = 4), which made accurate testing impossible. In addition, we performed
these statistical analyses using only the last urine sample obtained at the end of the day for
each worker to be consistent with other published studies in which only urine samples
obtained at the end of the workday were examined for exposure-biomarker association in
HDI exposed workers.6,26 These urine samples are hereon specified as end-of-day urine
samples.
Results
The mixed effects multiple linear regression models for predicting urinary HDA levels are
summarized in Table 2. Models built using either BZC (Models 1 and 3) or BZC-APF
(Models 2 and 4) with significant covariates were evaluated. The starting Models 1 and 2
originate from our previously published work3 and include only exposure variables and
creatinine. The final Models 3 and 4 include exposure variables, creatinine, and statistically
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significant individual and workplace factors. When tested individually (data not shown), the
only covariates with a p-value less than 0.15 were weekday (p = 0.056) and coveralls (p =
0.12).
In the original starting model for BZC (Model 1) containing only exposure variables and
creatinine, BZC exposure was not significant (p = 0.38). When respirator type was added to
the model along with the exposure variables, respirator type was significant (p = 0.082, data
not shown), but BZC exposure was not (p = 0.33). In the final BZC model containing
significant covariates (Model 3), respirator type (p = 0.11) and weekday (p = 0.10) were the
only significant covariates, and BZC was removed from the model since it was not
significant.
In the original starting model with BZC-APF (Model 2) containing only exposure variables
and creatinine, dermal exposure was not significant (p = 0.24). In the final model with BZC-
APF and covariates (Model 4), dermal exposure became even less significant and was
removed from the model. When the two significant covariates were both placed in a single
model (Model 4), both weekday (p = 0.05) and coveralls (p = 0.09) retained significance.
We further investigated the effect of weekday on urine HDA levels using ANOVA. BZC-
APF exposure did not significantly differ between the weekdays, but weekday was
borderline significant for dermal exposure (p = 0.11). The effect of weekday on exposure
levels was also evaluated using linear mixed modeling. Weekday was borderline significant
for BZC-APF exposure (p = 0.18) and significantly affected dermal exposure (p = 0.05).
Thus, significant variation on dermal exposure levels on different weekdays may have
contributed to the observation that weekday affected the levels of HDA in urine. However,
weekday was significant in both final linear regression models (Table 2, Models 2 and 4)
while dermal exposure was insignificant only in the final model with BZC-APF (Table 2,
Model 2). Therefore, since dermal exposure did not significantly affect HDA levels in this
model, weekday variation in dermal exposure by itself should not cause weekday to be a
significant variable in the model. Furthermore, in the final BZC model where dermal
exposure was significant (Table 2, Model 4), any weekday variation in dermal exposure
would be accounted for by the dermal exposure variable, and thus, the significance of
weekday in this model is independent of dermal exposure variability.
A summary of the hypothetical, pooled post-exposure urine HDA levels adjusted for
creatinine concentration and stratified by the different dichotomous and classification
covariates as well as the results of the ANOVA is provided in Table 3. Workers who wore
coveralls had significantly lower urine HDA levels (p = 0.05) than workers who did not
wear coveralls. Workers using a PAPR or air supply respirator, as opposed to a cartridge-
type respirator, had significantly lower urine HDA levels when the respirator was stratified
as a dichotomous covariate of cartridge-type respirator versus all others (p = 0.06). Painters
who worked in semi-downdraft or downdraft booths had significantly lower HDA levels
than those who worked in cross-draft booths (p = 0.02). Painters who worked at shops with
more than one painter had significantly higher levels of HDA than those who worked at a
shop where there was only one painter (p = 0.10). Smokers had borderline significantly
higher HDA levels than non-smokers (p = 0.12).
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No significant variables were observed to affect the end-of-day urine HDA levels adjusted
for creatinine concentration when stratified by the different dichotomous and classification
covariates (Table 3). Since we previously observed that smoking affected creatinine levels,8
we examined the urine HDA levels unadjusted for creatinine. Smokers had significantly
higher unadjusted HDA levels than non-smokers (p = 0.07; results not shown).
Stratification of the HDA levels twice allowed for analysis of the effect of dermal protection
within groups of similar respirator types (Table 4). The HDA levels were first stratified by
the use of cartridge-type respirators versus PAPR or air-supply respirators. Then, they were
stratified again by use of coveralls or gloves. Among workers who wore cartridge-type
respirators, those who wore coveralls had significantly lower post-exposure urine HDA
levels than those who did not wear coveralls (p = 0.10). No significant difference was
observed in post-exposure urine HDA levels between coverall users and non-users among
workers who used a PAPR or air-supply respirator. There was also no significant difference
in post-exposure urine HDA levels between workers wearing and not wearing gloves among
any respirator group. In addition, no significant differences were observed in HDA levels in
the end-of-day urine samples with any of these stratification methods.
The data was also stratified twice to determine if the reason for the differences between
HDA levels for smokers and non-smokers was due to differences in PPE use (Table 4). The
HDA levels were first stratified by the use of cartridge-type respirators versus PAPR or air-
supply respirators. Then, they were stratified again by the smoker status (yes, no). Among
workers using a PAPR or air-supply respirator, smoker status remained significant (p =
0.03). This procedure was repeated for coverall use. The HDA levels were stratified first by
coveralls use (yes, no). The data were then stratified by the smoker status (yes, no). Among
workers wearing coveralls, smoker status remained significant (p = 0.06). For the end-of-day
urine HDA levels, smoker status was significant, but only for workers wearing coveralls (p
= 0.05 for unadjusted HDA levels, and p = 0.10 for adjusted HDA levels).
Discussion
Previously, we reported that inhalation and dermal HDI exposure significantly affected the
urine HDA levels in workers occupationally exposed to HDI.3 We also determined that the
water content of urine should be accounted for by using creatinine concentration as an
independent variable in a linear regression model.3,8 Here, we examined individual and
workplace factors that may modify urine HDA levels in occupationally exposed workers and
how those factors affect exposure models.
We observed that painters who used the more protective PAPR or air-supply respirators had
significantly lower urine HDA levels than painters who wore cartridge-type respirators.
Respirator type was a significant variable in the linear regression model that used BZC
unadjusted for APF. BZC was not a statistically significant variable in the model when used
along with dermal exposure level and creatinine concentration. When respirator type was
added to the model, BZC retained its insignificance. Consequently, this lends support for the
use of BZC modified for APF to account for the inhalation exposure in the linear regression
models.
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Workers who wore coveralls and, thus, received some protection from dermal exposure, had
significantly lower urine HDA levels than those who did not wear coveralls (Table 3).
Austin reported similar results for workers dermally exposed to TDI.27 This significance
remained when the workers were stratified by respirator type to control for the effect of
differences in inhalation protection. Coverall use significantly lowered urine HDA levels
among painters wearing cartridge-type respirators, but not among painters wearing PAPR or
air-supply respirators. However, this result may be biased due to the small number of urine
samples obtained from workers wearing PAPR or air-supply respirator but not wearing
coveralls (N = 4).
Coverall use was also a significant predictor of urine HDA levels in the linear regression
models with BZC-APF exposure (Table 2). No other categorical variables that describe the
dermal PPE worn by the worker improved model fit. However, dermal exposure as
measured by the tape-strip method reflected the effect of PPE protection since the tape-strip
samples were taken from the areas that had been covered during painting.17 Thus, the
dermal exposure measured accounted for the protectiveness of the gloves or coverall.
However, the measured dermal exposure may have been underestimated due to the possible
rapid absorption of HDI through the stratum corneum and/or conjugation of HDI to
macromolecules in the skin. This may have contributed to the large number of non-
detectable samples collected from the skin (63%) even though the tape-strips were collected
immediately after each paint task. Further, although both final models included a dermal
exposure variable (coverall in Model 2 and dermal in Model 4), the high percentage of non-
detectable tape-strips may have led to an underestimation of dermal exposure's true
significance.
Painters in the multi-painter shops had significantly higher urine HDA levels than painters in
the single-painter shops. This indicates a bystander effect where painters are being exposed
to HDI through sources other than their painting tasks. Shops with more than one painter
may be busier and potentially have higher HDI-exposures, thus, increasing urine HDA
levels. However, no significant difference was observed in the cumulative daily BZC-APF
or dermal exposure between one- and multi-painter shops. Booth type was also found to
significantly affect urine HDA levels. Because Fent et al.15 previously observed that booth
type significantly affected BZCs in the same study population, this result was expected.
Booth type was not observed to be a significant variable in the linear regression models most
likely because booth type modified the exposure levels and was, therefore, accounted for in
the dermal and BZC-APF exposure variables.
Our ANOVA results showed smokers to have significantly higher HDA levels than non-
smokers. After stratification by cartridge-type respirator and coverall use to control for the
effect of different inhalation or dermal protection, the significance of smoking was retained
but only for the more protected workers (i.e., those wearing coveralls or PAPR or air-supply
respirators). In contrast, Liu et al.7 observed smokers to have lower urine HDA levels in a
group of healthy auto-body workers previously exposed to HDI. Neither current smoker
status or smoking history were observed to significantly affect urine HDA levels in the
linear regression models. This indicates that while smoking predicts urine HDA levels, it
does so to a much lesser degree than HDI-exposure and creatinine concentration. The reason
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why smoker status affected urine HDA levels in workers wearing more protective PPE is
unclear. It is plausible that smokers were exposed to HDI through ingestion by transferring
HDI from contaminated hands to cigarettes and mouth. The reason may also be biological. It
is plausible that HDI is eliminated faster in smokers due to tobacco smoke related induction
of metabolic enzymes.28 It is also plausible that HDA and toxins in tobacco smoke compete
for the same binding sites in macromolecules, and thus, due to potentially greater affinity of
tobacco toxins to macromolecules compared to HDA, HDA may be cleared faster from the
body. For example, benzo[a]pyrene, which is found in cigarette smoke, is known to bind
tightly to albumin.29 Perez-Reyes et al. proposed a similar reason to explain the rate of
increase in THC plasma concentrations in marijuana smokers.30
No other demographic variables improved the predictability in the linear regression models,
most likely due to the demographic similarities between the individuals in this small study
population. Further, the linear regression models were not affected by worker health
conditions (e.g., allergies, asthma). Weekday was found to significantly affect urine HDA
levels in the linear regression models. This finding supports our previous observation that
HDA has a biphasic elimination3 and may reflect the fact that HDA binds to
macromolecules in the body9,11,12 and, consequently, is slowly released or broken down
over time.
Finally, when we examined only the end-of-day urine samples, smoker status was the only
factor that significantly affected the urine HDA levels according to ANOVA. However, we
demonstrated previously that HDA levels can vary greatly throughout the day,3 and that the
short-term half-life of HDA is about 1.2–2.9 h.3,5,7,13,14 Therefore, the end-of-day sample
may not reflect the exposure dose received during the morning hours. Thus, the results
indicate the importance of collecting multiple urine samples throughout the day instead of
just one end-of-day spot sample.
Conclusion
This study provides further evidence that dermal exposure to HDI along with inhalation
exposure contribute to urine HDA levels. Further, this study demonstrates the importance of
proper dermal and inhalation protection during automotive spray painting with HDI-
containing paints. The results indicate differences in the effectiveness of the respiratory
protections used. Individual factors, with the exception of smoking status, were not observed
to significantly affect HDA levels, thus confirming the need to focus our efforts on exposure
reduction in work places. Also, evidence was provided for a bi-phasic elimination pattern of
HDA and the importance of collecting multiple urine samples throughout the workday to
reliably assess the contribution of the workday exposure to the HDA level.
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Urinary HDA can be used as a biomarker of exposure to HDI. However, a large variation
in the levels of HDA exists in occupationally exposed workers. Our goal was to
determine the individual and workplace factors that affect urine HDA levels after
accounting for HDI exposure and urine water content. The use of dermal and respiratory
protection was significantly associated with lower urine HDA levels. The presented
information will aid occupational and environmental health professionals and researchers
to determine methods to improve worker protection.
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Table 1
Summary of variables tested in linear regression models to predict urine HDA levels







Dichotomous Gloves Use of gloves 0: no, 1: yes 0.78 1 no
Long sleeves Use of long sleeves 0: no, 1: yes 0.05 0 no
Coverall Use of coveralls 0: no, 1: yes 0.67 1 no
Hat Use of hat 0: no, 1: yes 0.38 0 no
Goggles Use of goggles 0: no, 1: yes 0.17 1 no
Multi-painter shop Shop has more than one
painter
0: no, 1: yes 0.40 0 no
State Location of worker 0: NC, 1: WA 0.71 1 no
Smoker Current Smoker 0: no, 1: yes 0.32 0 no
Skin allergies Has skin allergies 0: no, 1: yes 0.02 0 no
Seasonal allergies Has season allergies 0: no, 1: yes 0.19 0 no
Year-round allergies Has year-round allergies 0: no, 1: yes 0.07 0 no
Allergy medicine Uses allergy medicine 0: no, 1: yes 0.12 0 no
Asthma Has asthma 0: no, 1: yes 0.09 0 no
Classification Ethnic group Worker's ethnicity 0: White, 1: Black, 2:




Smoker History Historical smoking 0: never, 1: past, 2:
current
0.89 1 no




Booth type Type of ventilated paint
booth
0: cross draft, 1: semi-
down draft, 2: down draft
1.5 2 no
Respirator type
c Type of respirator worn 0: half-face, 1: full-face,
2: air supplied hose or
PAPR
0.48 0 yes
Continuous Age Worker's age 21–59 34.2 34 yes
BMI Worker's BMI 18.7–38.8 28.3 27.4 yes
Years experience Worker's numbered years of
painting experience
0.25–40 12.6 11 no
Times painting in the
past week
Number of clear coat tasks
performed in past seven
days
0–45 14.0 12 yes
a
Mean and median values are based on worker-visits. A worker who was visited three times, would have his response used in the calculation three
times. Mean and median for dichotomous and categorical variables, are based on the numeric value of each response as indicated in range of
values.
b
Variables, designated as tested with interaction, were tested with interaction with dermal and BZC-APF exposure.
c
Variable, respirator type, was only used in model with BZC, not in the models with BZC-APF.
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Table 2
Summary of the linear mixed models for predicting natural log-transformed, post-exposure urinary HDA
concentrations in the spray-painters using unadjusted (BZC, Models 1 and 3) or APF adjusted BZC levels
(BZC-APF, Models 2 and 4). The starting Models 1 and 2 originate from our previously published work3 and
include only exposure variables and creatinine. The final Models 3 and 4 include exposure variables,
creatinine, and statistically significant individual and workplace factors.
a
Model Variable Estimate Standard error p-value AIC R2
1. Starting model with BZC InBZC 0.08 0.09 0.38 1038 0.25
Indermal 0.11 0.07 0.12
Increatinine 1.25 0.17 <0.0001
worker var 0.99 0.07
residual var 1.78 0.15
2. Starting model with BZC-APF InBZC-APF 0.14 0.06 0.03 1035 0.28
Indermal 0.08 0.07 0.24
Increatinine 1.28 0.17 <0.0001
worker var 0.93 0.07
residual var 1.76 0.15
3. Final model with BZC
b Indermal 0.16 0.06 0.01 1025 0.29
Increatinine 1.35 0.17 <0.0001
Half-face 0.62 0.39 0.11
Full-face 1.33 0.70




worker var 1.00 0.10
residual var 1.11 0.15
4. Final model with BZC-APF InBZC-APF 0.19 0.06 0.001 1025 0.29
Increatinine 1.34 0.17 <0.0001




coverall −0.48 0.29 0.09
worker var 1.01 0.09
residual var 1.68 0.15
a
InBZC = natural log-transformed breathing zone concentration; InBZC-APF = natural log-transformed respirator adjusted breathing zone
concentration; Indermal = natural log-transformed dermal exposure; Increatinine = natural log-transformed creatinine concentration; AIC =
Akaike's Information Criterion; var = variance.
b
BZC was removed from the final model since it was not statistically significant.
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Table 3
Post-exposure and the end-of-day urine HDA levels
a
 adjusted for creatinine concentration and stratified by
workplace and individual factors.
b
Pooled post-exposure urine (μg HDA/g
creatinine)
End-of-day urine (μg HDA/g
creatinine)
Variable Level n N GM GSD p-value GM GSD p-value
Coverall no 14 38 0.16 3.48 0.05 0.13 4.95 0.21
yes 33 77 0.09 4.94 0.08 5.60
Gloves no 8 25 0.14 3.51 0.29 0.12 5.07 0.41
yes 39 90 0.10 4.80 0.09 5.52
Long sleeves no 41 109 0.11 4.65 0.89 0.10 5.62 0.47
yes 6 6 0.11 2.65 0.13 2.54
Hat no 26 71 0.13 4.56 0.22 0.10 5.76 0.56
yes 21 44 0.09 4.39 0.09 4.92
Googles no 37 95 0.12 4.49 0.15 0.10 5.76 0.56
yes 10 20 0.07 4.37 0.09 4.92
Respirator PAPR/air supply 10 26 0.07 3.92 0.06 0.07 4.72 0.23
cartridge 38 88 0.13 4.63 0.11 5.65
APF respirator type 1 1 1 0.09 1.00 0.23 0.09 1.00 0.44
10 37 85 0.12 4.70 0.07 5.73
50 1 3 0.30 1.76 0.32 1.91
1000 10 26 0.07 3.92 0.07 4.72
Booth type cross 9 20 0.25 2.60 0.02 0.18 3.53 0.20
semi 7 17 0.09 4.33 0.09 5.59
down 31 78 0.09 4.79 0.08 5.76
Multipainter shop no 28
c 68 0.09 4.48 0.10 0.08 5.09 0.28
yes 19 47 0.15 4.38 0.12 5.86
Location North Carolina 14 33 0.11 4.57 0.91 0.10 5.26 0.75
Washington 33 82 0.11 4.53 0.09 5.52
Weekday Monday 18 18 0.08 3.77 0.47 0.07 4.76 0.47
Tuesday 23 23 0.15 5.21 0.13 6.39
Wednesday 34 34 0.10 4.59 0.11 5.75
Thursday 24 24 0.15 4.49 0.12 4.56
Friday 16 16 0.08 3.78 0.05 4.80
Current smoker no 33 78 0.09 4.88 0.12 0.08 5.66 0.16
yes 16 37 0.15 3.67 0.13 4.78
Ethnicity Caucasian 31 78 0.11 4.51 0.33 0.10 5.63 0.58
African-American 4 6 0.06 6.57 0.06 5.89
Hispanic 9 19 0.15 3.22 0.13 4.00
Asian 1 3 0.03 3.12 0.04 3.60
Native American 1 3 0.23 1.55 0.25 1.32
mixed 2 6 0.07 6.81 0.06 8.67
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a
Pooled, post-exposure urine level includes all urine samples collected from a painter after at least one exposure had occurred while the end-of-day
urine level was measured in the last urine sample of the workday.
b
n = number of workers (may not always total 47, since workers would change PPE use or other factors between visits; two workers quit smoking
between visits); N = number of worker-days; GM = geometric mean; GSD = geometric standard deviation.
c
Number is based on painters participating in this study. Some shops may have had another painter who did not participate in the study.
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